WILMINGTON, Del.--(BUSINESS WIRE)--Jul 12, 2018--Incyte Corporation (Nasdaq:INCY) announced today that it has scheduled its second quarter 2018 financial results conference call and webcast for 8:00 a.m. ET on Tuesday, July 31, 2018.

The schedule for the press release and conference call/webcast is as follows:

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415 . To access the replay you will need the conference ID number 13681303.

The live webcast with slides can be accessed at www.incyte.com under For Investors, Events and Presentations and will be available for replay for 30 days.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Company's website at www.incyte.com.

Follow @Incyte on Twitter at https://twitter.com/Incyte.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180712005015/en/

CONTACT: Incyte Corporation

Investors

Michael Booth, DPhil, +1 302-498-5914

mbooth@incyte.com

or

Media

Catalina Loveman, +1 302-498-6171

cloveman@incyte.com

KEYWORD: UNITED STATES NORTH AMERICA DELAWARE

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL

SOURCE: Incyte Corporation

Copyright Business Wire 2018.

PUB: 07/12/2018 08:00 AM/DISC: 07/12/2018 08:01 AM

http://www.businesswire.com/news/home/20180712005015/en